Obeticholic Acid

Effective Treatment for Liver Diseases & Cholestasis Management

Key Benefits

• Cholestasis Treatment: Obeticholic Acid is used for the treatment of primary biliary cholangitis (PBC) and other cholestatic liver diseases by improving bile acid flow and liver function

• FXR Agonist: Activates the Farnesoid X receptor (FXR) to regulate bile acid synthesis and promote liver health

• Liver Protection: Protects the liver from damage and reduces inflammation caused by liver diseases

• Helps Improve Fibrosis: Shown to reduce liver fibrosis, promoting the regeneration of liver cells

• Advanced Pharmaceutical Development: Crucial for pharmaceutical formulations targeting liver diseases and cholestasis

Applications

• Liver Disease Treatment: Used in the treatment of primary biliary cholangitis (PBC) and non-alcoholic steatohepatitis (NASH)

• Pharmaceutical Manufacturing: Incorporated in the production of advanced liver disease treatments

• Research & Development: Used in the development of new drugs for liver conditions and cholestatic diseases

• Supplementation: Potential for inclusion in nutraceuticals targeting liver detoxification and health

• Preclinical & Clinical Studies: Used in studies focused on liver protection and fibrosis management

•